Abstract Number: 0205 • ACR Convergence 2021
An Observational Study from the Perspective of Rheumatology in the Management of Patients with Psoriatic Arthritis in Turkey – LOOP Study
Background/Purpose: Available evidence suggests that timely and effective management of patients with psoriatic arthritis (PsA) can improve long-term outcomes. Current information on the factors which…Abstract Number: 1082 • ACR Convergence 2021
The Rheumatology Workforce in Canada: Results of the Workforce and Wellness Survey
Background/Purpose: A rheumatology workforce survey conducted in Canada in 2015 predicted a looming critical shortage of rheumatologists, with one third of surveyed rheumatologists indicating plans…Abstract Number: 155 • 2019 ACR/ARP Annual Meeting
A Prospective, Unblinded, Non-randomized Pilot Study Examining the Effect of a Musculoskeletal Immersion Curriculum for First Year Internal Medicine Residents
Background/Purpose: Musculoskeletal (MSK) disorders are one of the most common clinic visit complaints. Prior studies evaluating graduate medical training of rheumatology and MSK medicine have…Abstract Number: 259 • 2019 ACR/ARP Annual Meeting
Describing Treatment Patterns and Healthcare Costs in Newly Diagnosed Psoriatic Arthritis Patients by Physician Specialty
Background/Purpose: The clinical heterogeneity of psoriatic arthritis (PsA) presents a variety of diagnostic and treatment challenges, which may be reflected in the way different health…Abstract Number: 1213 • 2019 ACR/ARP Annual Meeting
A Retrospective Review and Prospective Intervention for Outpatient Follow-Up of Hospitalized Patients in Rheumatology
Background/Purpose: There is lack of appropriate outpatient follow-up (F/U) for hospitalized rheumatology patients, which can result in disease recurrence and recurrent inpatient admissions1. This is…Abstract Number: 2093 • 2019 ACR/ARP Annual Meeting
Safety of Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su, Shingrix) Among Patients with Autoimmune Inflammatory Diseases
Background/Purpose: HZ/su has been in use since 2017 and is recommended by the advisory committee on immunization practices (ACIP) as the preferred shingles vaccine due…Abstract Number: 2304 • 2019 ACR/ARP Annual Meeting
Bone Microstructure of Patients with Rheumatoid Arthritis: A HR-pQCT Study
Background/Purpose: In rheumatoid arthritis (RA), it has been reported that osteoclast are activated by immune complexes, anti-CCP antibodies (ACPAs), and inflammatory cytokines. The purpose of…Abstract Number: 191 • 2018 ACR/ARHP Annual Meeting
Creation of an Immunology Series Video Library in Facilitating Basic Immunology Knowledge Acquisition and Retention Amongst Adult Rheumatology Trainees
Background/Purpose: A strong foundational knowledge in immunology is key to understanding complex rheumatologic disease processes. Indeed, an immunology curriculum delivered by Rheumatology training programs across…Abstract Number: 97 • 2017 ACR/ARHP Annual Meeting
Medical Student Interest in Rheumatology As a Career
Background/Purpose: Based on data from the Rheumatology Workforce Study, there are insufficient rheumatologists to serve the needs of the population. Little is currently known about…Abstract Number: 912 • 2017 ACR/ARHP Annual Meeting
Has the Attractiveness of a Career in Rheumatology Changed for the Better? Comparison of Trends in the Rheumatology Fellowship Match from 2014 to 2017 with 2008 to 2013
Background/Purpose: Rheumatology has been a less attractive career choice than most other medical subspecialties for many years. The 2015 American College of Rheumatology (ACR)…Abstract Number: 2046 • 2017 ACR/ARHP Annual Meeting
Development and Validation of a Rheumatologist Satisfaction with Practice Scale –“ the Rheumatologist Satisfaction Scale” (RSS)
Background/Purpose: Practice improvement research routinely measures patient satisfaction and disease-specific outcomes but seldom considers the satisfaction of physicians who deliver the care. Studies suggest that…Abstract Number: 3027 • 2016 ACR/ARHP Annual Meeting
Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib
Background/Purpose: Compared to the general population, RA patients (pts) have an increased risk of herpes zoster (HZ) due to their disease and various DMARD therapies…Abstract Number: 1142 • 2016 ACR/ARHP Annual Meeting
Impact of a Student Led Rheumatology Interest Group on Medical Student Interest in Rheumatology
Impact of a Student Led Rheumatology Interest Group on Medical Student Interest in Rheumatology Background/Purpose: Based on data from the 2005 Rheumatology Workforce Study the…Abstract Number: 1584 • 2016 ACR/ARHP Annual Meeting
Bari-00074565
Background/Purpose: Baricitinib is an oral selective inhibitor of Janus kinases 1/2 and has demonstrated dose-dependent efficacy in moderate-to-severe RA patients who were DMARD-naïve or with…Abstract Number: 1585 • 2016 ACR/ARHP Annual Meeting
Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
Background/Purpose: Baricitinib (BARI), an oral JAK1/JAK2 inhibitor, is in development for patients (pts) with moderate to severe RA.1,2 The purpose of this post hoc analysis…